Tietel Zipora, Melamed Sarit, Ogen-Shtern Navit, Eretz-Kdosha Noy, Silberstein Eldad, Ayzenberg Tomer, Dag Arnon, Cohen Guy
Food Science, Gilat Research Center, Agricultural Research Organization-Volcani Institute, Rishon LeZion, Israel.
The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Jerusalem, Israel.
Front Pharmacol. 2024 Jan 26;15:1333085. doi: 10.3389/fphar.2024.1333085. eCollection 2024.
Jojoba ( L.) wax was previously reported to increase cutaneous wound healing, ameliorate acne and psoriasis manifestations, and reduce oxidative stress and inflammation. However, its potential cosmetic properties have not been fully investigated. Thus, the current study aimed to evaluate the anti-inflammatory activities of jojoba wax and its impact on the synthesis of extracellular components following topical application. The fatty acid and fatty alcohol profiles of two industrial and two lab-scale cold-press jojoba waxes were analyzed along with total tocopherol and phytosterol content. The dermo-cosmetic effect of all jojoba wax preparations was evaluated , using the human skin organ culture model, which emulates key features of intact tissue. The ability of jojoba wax to reduce secreted levels of key pro-inflammatory cytokines and the safety of the applications in the model were evaluated. In addition, the impact on the synthesis of pro-collagen and hyaluronic acid levels upon treatment was investigated. The results demonstrate that topically applied jojoba wax can reduce LPS-induced secretion of IL-6, IL-8, and TNFα by approx. 30% compared to untreated skin. This effect was enhanced when treatment was combined with low non-toxic levels of Triton X-100, and its efficacy was similar to the anti-inflammatory activity of dexamethasone used as a positive control. In addition, mRNA and protein levels of collagen III and synthesis of hyaluronic acid were markedly increased upon topical application of jojoba. Moreover, the enhanced content of extracellular matrix (ECM) components correlated with the enhanced expression of TGFβ1. Collectively, our results further demonstrate that jojoba can reduce local skin inflammation, and this effect may be increased by emulsifier which increases its bioavailability. In addition, the finding that topical application of jojoba wax enhances the synthesis of pro-collagen and hyaluronic acid and may be beneficial in the treatment of age-related manifestations.
先前有报道称霍霍巴蜡可促进皮肤伤口愈合、改善痤疮和银屑病症状,并减轻氧化应激和炎症。然而,其潜在的美容特性尚未得到充分研究。因此,本研究旨在评估霍霍巴蜡的抗炎活性及其局部应用后对细胞外成分合成的影响。分析了两种工业规模和两种实验室规模冷榨霍霍巴蜡的脂肪酸和脂肪醇谱,以及总生育酚和植物甾醇含量。使用模拟完整组织关键特征的人体皮肤器官培养模型,评估了所有霍霍巴蜡制剂的皮肤美容效果。评估了霍霍巴蜡降低关键促炎细胞因子分泌水平的能力以及该制剂在该模型中的安全性。此外,还研究了治疗后对前胶原合成和透明质酸水平的影响。结果表明,与未处理的皮肤相比,局部应用霍霍巴蜡可使脂多糖诱导的白细胞介素-6、白细胞介素-8和肿瘤坏死因子α分泌减少约30%。当治疗与低无毒水平的曲拉通X-100联合使用时,这种效果会增强,其疗效与用作阳性对照的地塞米松的抗炎活性相似。此外,局部应用霍霍巴蜡后,胶原蛋白III的mRNA和蛋白质水平以及透明质酸的合成均显著增加。此外,细胞外基质(ECM)成分含量的增加与转化生长因子β1表达的增强相关。总的来说,我们的结果进一步证明,霍霍巴蜡可以减轻局部皮肤炎症,乳化剂可提高其生物利用度,从而增强这种效果。此外,局部应用霍霍巴蜡可增强前胶原和透明质酸的合成,这一发现可能对治疗与年龄相关的症状有益。